Valbenazine (ingrezza): the First FDA-Approved Treatment for Tardive Dyskinesia.Stepan Uhlyar,Jose A ReyPubMed(2018)引用 28|浏览2暂无评分摘要Valbenazine (Ingrezza): the first FDA-approved treatment for tardive dyskinesia.更多查看译文AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要